1. DOP45 Utilization and sustainability of biologics in CD - A nationwide study from the epi-IIRN. (27th May 2021) Authors: Atia, O; Yogev, D; Chagit, F; Gili, F; Orlanski-Meyer, E; Magen Rimon, R; Natan, L; Shira, G; Kariv, R; Yisca, L W; Gabay, H; Nevo, D; Matz, E; Gorelik, Y; Chowers, Y; Iris, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP58 predictors of complicated disease course in CD in an administrative database: a nationwide study from the epi-IIRN. (30th January 2023) Authors: Lujan, R; Atia, O; Gili, F; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗